A heads up alert to patients considering or now using Therapies containing PD-1 or PD-L1 Checkpoint inhibitors.
cancernetwork.com/ata-2016-...
Quote from article: "The risk of immunotherapy-related destructive thyroiditis requires close patient monitoring and can cause permanent hypothyroidism"
WWW
Thank you WWW.
I am wondering if anyone is having thyroid issues with either Ibrutinib or Acalabrutinib?
I was warned by my MD Anderson consultant to carefully have my thyroid and metabolism watched when I started (any) treatment. I gained 10 lbs in 6 weeks on Acalabrutinib without change in diet or activity level. My trial doctor (NIH) says they know of no thyroid/metabolism link with the drug. Any thoughts?
Trudy
Acalabrutinib is a much more specific BTK inhibitor than Ibrutinib which has demonstrated fewer adverse side effects than Ibrutinib. There are 3 main side effects listed in this recent paper for Acalabrutinib in which weight gain is one. No mention for explanation which does not rule out thyroid interaction. We will have to wait to see if any correlation is revealed. If you were warned to get your thyroid checked it is almost certain that a suspicion without proof is afoot.
jhoonline.biomedcentral.com...
WWW
Long-Term Ibrutinib Therapy Reverses CD8+ T Cell Exhaustion in B Cell CLL
Ibrutinib Side Effect???
ASH 2018: Dr. Chadi Nabhan on the Cost of Ibrutinib vs. Chemo vs Chemoimmunotherapy in CLL and on way too much chemo being used.
Can Your Body Be Trained to Cure Its Own Cancer? Possible side effects from Ibrutinib & Idelalisib
